Lifevantage Corp - FORM 10-K - EX-10.30 - AMENDMENT OF SCIENTIFIC ADVISORY BOARD AGREEMENT - September 28, 2011

Attached files

file filename
EX-23.1 - CONSENT OF EHRHARDT KEEFE STEINER & HOTTMAN PC - Lifevantage Corpd225491dex231.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - Lifevantage Corpd225491dex311.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - Lifevantage Corpd225491dex322.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - Lifevantage Corpd225491dex321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - Lifevantage Corpd225491dex312.htm
EX-10.32 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DR. JOE MCCORD - Lifevantage Corpd225491dex1032.htm
EX-10.33 - FORMS OF INCENTIVE STOCK OPTION AND NONQUALIFYING STOCK OPTION AGREEMENTS - Lifevantage Corpd225491dex1033.htm
EX-10.31 - EMPLOYMENT AGREEMENT WITH DR. JOE MCCORD - Lifevantage Corpd225491dex1031.htm
10-K - FORM 10-K - Lifevantage Corpd225491d10k.htm
EX-3.2 - AMENDED AND RESTATED BYLAWS - Lifevantage Corpd225491dex32.htm
EX-3.1 - AMENDED AND RESTATED ARTICLES OF INCORPORATION - Lifevantage Corpd225491dex31.htm

Exhibit 10.30

AMENDMENT OF SCIENTIFIC ADVISORY BOARD AGREEMENT

This Amendment of the Scientific Advisory Board Agreement (“Amendment”) is made and entered into as of July 21, 2011 (“Execution Date”) by and between Dr. Joe M. McCord, Ph.D., (“Consultant”) and LifeVantage Corporation, a Colorado Corporation (the “Company”).

RECITALS

A. Company and Consultant are parties to a certain Scientific Advisory Board Agreement dated October 9, 2009. (“Agreement”)

B. The parties wish to amend the Agreement to extend the term.

AMENDMENT

NOW, THEREFORE, in consideration of the foregoing terms and the mutual promises set forth in this Amendment and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

1. Term. The undersigned agree to amend Dr. McCord’s Scientific Advisory Board Agreement to extend the existing terms and conditions for an additional twelve (12) months period beginning July 1, 2010 (“Effective Date”) and ending on June 30, 2011, (the “Term”).

2. Counterparts. This Amendment may be executed in two or more counterparts each of which shall be deemed an original and which together shall constitute one instrument.

This Amendment has been executed as of the date first set forth above, with such execution being effective as of the effective date of the Agreement.

 

LifeVantage Corporation     Consultant
By:   /S/    DOUGLAS C. ROBINSON             /S/    DR. JOE M. MCCORD PH.D.        
Name:   Douglas C. Robinson     Dr. Joe M. McCord Ph.D.
Title:   Chief Executive Officer    

Stock widget

Investing forum

Lifevantage Corp Reports